Latest guidelines, novel therapies and emerging options for managing dyslipidemias and ASCVD risk in daily practice
After watching this activity, participants should be better able to:
- Choose appropriate lipid goals for patients with dyslipidemias and at risk of ASCVD, considering the latest guidelines
- Formulate guideline-based and forward-thinking strategies to reduce ASCVD risk in patients with dyslipidemias using appropriate lipid- and lipoprotein-lowering therapies
- Recognize special populations of patients with dyslipidemias and apply important considerations when treating them with lipid- and lipoprotein-lowering therapies
In this activity, experts in the management of dyslipidemias and ASCVD respond to questions from the cardiology community on lipid goals for patients with dyslipidemias and at risk of ASCVD. They discuss strategies to reduce ASCVD risk in such patients using appropriate lipid- and lipoprotein-lowering therapies, and important considerations for managing special populations of patients with dyslipidemias.
This activity is provided by touchIME.
To obtain the CE credit(s) from this activity, please complete this post-activity test.Claim Credit
You may also be interested in...
Latest guidelines, novel therapies and emerging options for managing dyslipidemias and ASCVD risk in daily practiceThis activity is CE/CME accredited
Zsolt Piroth, TCT 2022: The value of post-PCI FFR and intravascular imaging for cardiovascular failure, a FAME 3 substudy
Milind Desai, ACC 2022: VALOR-HCM: Mavacamten as an alternative to surgical septal myectomy or alcohol ablation in patients with severely symptomatic obstructive hypertrophic cardiomyopathy
Multidisciplinary team insights on the promise of new and emerging treatment options for patients with HFrEFThis activity is CE/CME accredited
Physicians’ acquaintance with a new procedure results in higher patient referral: experience of Kosovo in coronary angiography
82/Cardiac ablation in premature ventricular contraction-induced cardiomyopathy
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!